Coordinated and aggressive multidisciplinary team management for all aspects of CF-associated complications has improved CF care by alleviating symptoms and improving morbidity, quality of life, and long-term prognosis, despite none of these therapies specifically addressing the core problem—the need to restore CFTR function. This evidence concerns the gene CFTR and cystic fibrosis.